Related Experiment Video
Updated: Jul 17, 2026

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
Published on: December 19, 2025
Acute ischemic stroke, active malignancy and non-bacterial thrombotic endocarditis: an exploratory prospective
Athanasios Frydas1,2,3,4, Ela Marie Akay5, Hong Ran1,6
1Deutsches Herzzentrum der Charité, Department of Cardiology, Angiology and Intensive Care Medicine, Berlin, Germany.
Active cancer patients with acute ischemic stroke (AIS) often have malignancy-associated hypercoagulability (MAH). Nonbacterial thrombotic endocarditis (NBTE), a severe MAH form, was frequently found, suggesting LMWH may be better than DOACs for anticoagulation.
Area of Science:
- Neurology
- Cardiology
- Oncology
Background:
- 3-10% of acute ischemic stroke (AIS) patients have active cancer.
- Malignancy-associated hypercoagulability (MAH) is a known cause of cancer-associated stroke.
- Nonbacterial thrombotic endocarditis (NBTE) is a severe manifestation of MAH, but its prevalence and management in AIS are not well-studied prospectively.
Purpose of the Study:
- To prospectively examine the prevalence of NBTE in patients with AIS/transient ischemic attack (TIA) and active malignancy.
- To investigate the association of NBTE with stroke patterns.
- To evaluate anticoagulation management and outcomes in this patient group.
Main Methods:
- Prospective observational study at a tertiary center.
- Included patients with AIS/TIA and active malignancy.
- Echocardiography (transthoracic and transesophageal) was performed. Data on anticoagulation and outcomes were collected.
Main Results:
- Out of 3,491 screened patients, 16 with active cancer and AIS/TIA were included.
- Eleven patients (68.8%) showed embolic patterns suggestive of MAH.
- Six patients (37.5%) were diagnosed with NBTE. NBTE patients had a higher incidence of multi-territory embolic infarctions (100% vs. 60%) and prior strokes (66.7% vs. 10%).
- Low-molecular-weight heparin (LMWH) led to vegetation resolution/regression in 3/4 patients, while direct oral anticoagulants (DOACs) were associated with progression or recurrent embolism in several patients.
- Twelve-month mortality was high in both MAH (90.9%) and NBTE (83.3%) groups.
Conclusions:
- NBTE is frequently identified in patients with cancer-associated stroke and linked to multi-territory embolic infarction.
- Early recognition of NBTE may aid diagnosis.
- Optimal anticoagulation strategies require further investigation, with preliminary findings suggesting LMWH may be more effective than DOACs.
Related Concept Videos
Endocarditis I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Ischemic Stroke l: Introduction
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis